bioMérieux: H1 2019 net income up 4.7%
(CercleFinance.com) - bioMérieux has published H1 2019 net income, group share that is up 4.
7% at 141 million euros, with contributive operating income before non-recurring items of 198 million, or 15.5% of sales, in the line with its annual targets.
At 30 June 2019, sales of the in-vitro diagnostics group reached 1,275 million euros, up 5.5% in organic terms. Growth reached 9.1% as reported, boosted by positive FX factors, including the strengthening of the dollar.
biomereux has confirmed its targets for 2019, including between 7% and 8.5% organic sales growth at constant exchange rate and consolidation scope, with contributive operating income of between 385 million and 400 million euros at current exchange rates.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
7% at 141 million euros, with contributive operating income before non-recurring items of 198 million, or 15.5% of sales, in the line with its annual targets.
At 30 June 2019, sales of the in-vitro diagnostics group reached 1,275 million euros, up 5.5% in organic terms. Growth reached 9.1% as reported, boosted by positive FX factors, including the strengthening of the dollar.
biomereux has confirmed its targets for 2019, including between 7% and 8.5% organic sales growth at constant exchange rate and consolidation scope, with contributive operating income of between 385 million and 400 million euros at current exchange rates.
Copyright (c) 2019 CercleFinance.com. All rights reserved.